International Peer-Reviewed JournalOpen AccessISSN 2456-8880
irejournals@gmail.com+91-7433024337

Home / Current Issue / Paper 1713238

1713238PublishedVol 9 · Issue 7

Complications Over OTC: A Comprehensive Analysis of Risks, Misuse, and Regulatory Challenges in Over-the-Counter Medications

Galaba Yamini Padmasri Pusunuri Pranitha Chiruvolulanka Dharmik Ram Teja Subhadeep Pratihar Varshitha Asukolla

Subject area: Biological & Medical Sciences  ·  Area of research: Pharmacy

DOI: https://doi.org/10.64388/IREV9I7-1713238

Abstract

Over-the-counter (OTC) medications are widely used for the management of minor and self-limiting health conditions due to their accessibility and convenience. However, inappropriate use in the absence of professional supervision has emerged as a significant contributor to preventable adverse health outcomes, particularly in low- and middle-income settings such as India. Misuse of OTC drugs commonly involves excessive dosing, prolonged consumption, polypharmacy, and failure to recognize contraindications or clinically relevant drug interactions. This review examines complications associated with the unsupervised use of commonly available OTC medications, including nonsteroidal anti-inflammatory drugs, antihistamines, antacids and acid-suppressing agents, cough suppressants, laxatives, and topical corticosteroids. The discussion integrates pharmacological mechanisms of toxicity with clinical evidence describing organ-specific adverse effects involving the gastrointestinal, renal, hepatic, cardiovascular, and neurological systems. Increased vulnerability among elderly individuals, pregnant women, children, and patients with chronic illnesses is highlighted. Regulatory challenges governing OTC medicines in India are critically evaluated in comparison with international practices, with emphasis on gaps in pharmacovigilance, labeling, and post- marketing surveillance. The role of community pharmacists in promoting rational OTC use through patient counseling and early risk identification is also discussed. Strengthening regulatory oversight and public health education is essential to reduce avoidable harm while maintaining therapeutic accessibility.

Keywords

Over-The-Counter Medications, Self-Medication, Adverse Drug Reactions, Pharmacovigilance, Public Health; Pharmaceutical Regulation

How to cite this paper

Galaba Yamini Padmasri, Pusunuri Pranitha, Chiruvolulanka Dharmik Ram Teja , Subhadeep Pratihar, Varshitha Asukolla "Complications Over OTC: A Comprehensive Analysis of Risks, Misuse, and Regulatory Challenges in Over-the-Counter Medications" Iconic Research And Engineering Journals Volume 9 Issue 7 2026 Page 68-83 https://doi.org/10.64388/IREV9I7-1713238
Galaba Yamini Padmasri, Pusunuri Pranitha, Chiruvolulanka Dharmik Ram Teja , Subhadeep Pratihar, Varshitha Asukolla "Complications Over OTC: A Comprehensive Analysis of Risks, Misuse, and Regulatory Challenges in Over-the-Counter Medications" Iconic Research And Engineering Journals, vol. 9, no. 7, Jan. 2026, doi: https://doi.org/10.64388/IREV9I7-1713238
Galaba Yamini Padmasri, Pusunuri Pranitha, Chiruvolulanka Dharmik Ram Teja , Subhadeep Pratihar, Varshitha Asukolla (2026). Complications Over OTC: A Comprehensive Analysis of Risks, Misuse, and Regulatory Challenges in Over-the-Counter Medications. Iconic Research And Engineering Journals, 9(7). doi: https://doi.org/10.64388/IREV9I7-1713238
Galaba Yamini Padmasri, Pusunuri Pranitha, Chiruvolulanka Dharmik Ram Teja , Subhadeep Pratihar, Varshitha Asukolla "Complications Over OTC: A Comprehensive Analysis of Risks, Misuse, and Regulatory Challenges in Over-the-Counter Medications" Iconic Research And Engineering Journals, vol. 9, no. 7, Jan. 2026. Crossref, https://doi.org/10.64388/IREV9I7-1713238
@article{1713238,
      author = {Galaba Yamini Padmasri, Pusunuri Pranitha, Chiruvolulanka Dharmik Ram Teja , Subhadeep Pratihar, Varshitha Asukolla},
      title = {Complications Over OTC: A Comprehensive Analysis of Risks, Misuse, and Regulatory Challenges in Over-the-Counter Medications},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {7},
      pages = {68-83},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1713238.pdf},
      abstract = {Over-the-counter (OTC) medications are widely used for the management of minor and self-limiting health conditions due to their accessibility and convenience. However, inappropriate use in the absence of professional supervision has emerged as a significant contributor to preventable adverse health outcomes, particularly in low- and middle-income settings such as India. Misuse of OTC drugs commonly involves excessive dosing, prolonged consumption, polypharmacy, and failure to recognize contraindications or clinically relevant drug interactions. This review examines complications associated with the unsupervised use of commonly available OTC medications, including nonsteroidal anti-inflammatory drugs, antihistamines, antacids and acid-suppressing agents, cough suppressants, laxatives, and topical corticosteroids. The discussion integrates pharmacological mechanisms of toxicity with clinical evidence describing organ-specific adverse effects involving the gastrointestinal, renal, hepatic, cardiovascular, and neurological systems. Increased vulnerability among elderly individuals, pregnant women, children, and patients with chronic illnesses is highlighted. Regulatory challenges governing OTC medicines in India are critically evaluated in comparison with international practices, with emphasis on gaps in pharmacovigilance, labeling, and post- marketing surveillance. The role of community pharmacists in promoting rational OTC use through patient counseling and early risk identification is also discussed. Strengthening regulatory oversight and public health education is essential to reduce avoidable harm while maintaining therapeutic accessibility.},
      keywords = {Over-The-Counter Medications, Self-Medication, Adverse Drug Reactions, Pharmacovigilance, Public Health; Pharmaceutical Regulation},
      month = {January},
      doi = {https://doi.org/10.64388/IREV9I7-1713238}
  }